Open Access
Applying Emax model and bivariate thin plate splines to assess drug interactions
Maiying Kong1,J Jack Lee1
Department of Bioinformatics and Biostatistics, School of Public Health and Information Sciences, University of Louisville, Louisville, Kentucky 40292, USA
DOI: 10.2741/E90 Volume 2 Issue 1, pp.279-292
Published: 01 January 2010

We review the semiparametric approach previously proposed by Kong and Lee and extend it to a case in which the dose-effect curves follow the Emax model instead of the median effect equation. When the maximum effects for the investigated drugs are different, we provide a procedure to obtain the additive effect based on the Loewe additivity model. Then, we apply a bivariate thin plate spline approach to estimate the effect beyond additivity along with its 95 per cent point-wise confidence interval as well as its 95 per cent simultaneous confidence interval for any combination dose. Thus, synergy, additivity, and antagonism can be identified. The advantages of the method are that it provides an overall assessment of the combination effect on the entire two-dimensional dose space spanned by the experimental doses, and it enables us to identify complex patterns of drug interaction in combination studies. In addition, this approach is robust to outliers. To illustrate this procedure, we analyzed data from two case studies.

Share and Cite
Maiying Kong, J Jack Lee. Applying Emax model and bivariate thin plate splines to assess drug interactions. Frontiers in Bioscience-Elite. 2010. 2(1); 279-292.